ERBB2 and neoplasm: It is believed that such destabilization of client proteins (like raf, Src, Lck, Wee1, Mek, Cdk4, Src, Ck2, Akt, ErbB2 etc.)is responsible for the anti-mitotic and anti-tumor activity of the drug.